What is the recommended evaluation and treatment for urinary tract infections in adult men?

Urinary Tract Infections in Men: Evaluation and Treatment

All UTIs in men should be considered complicated and treated accordingly, requiring 7-14 days of antibiotics (14 days when prostatitis cannot be excluded), with mandatory urine culture before initiating empiric therapy. 1

Key Principle: UTI in Males = Complicated UTI

The 2024 European Association of Urology guidelines explicitly classify "urinary tract infection in males" as a factor associated with complicated UTIs. 1 This fundamental classification drives all subsequent management decisions and distinguishes male UTIs from the simpler approach used in women.

Diagnostic Evaluation

Essential Testing

• Urine culture with susceptibility testing is mandatory before starting antibiotics in all men 1, 2
• Obtain culture even for afebrile cystitis-like symptoms
• Culture thresholds: ≥10³ CFU/mL with leukocyturia >30 × 10³/mL 3

Clinical Assessment

Determine the anatomic location:

• Cystitis: Dysuria, urgency, frequency, suprapubic pain WITHOUT fever
• Prostatitis: Cystitis symptoms PLUS fever/sepsis (cannot always be excluded in men, hence 14-day treatment default)
• Pyelonephritis: Fever, flank pain/costovertebral angle tenderness ± cystitis symptoms
• Epididymo-orchitis: Testicular/scrotal pain and swelling (requires STI screening) 3

When to Image

• Urgent imaging (CT or ultrasound): Sepsis, suspected obstruction, or failure to improve within 48-72 hours
• Pyelonephritis requires imaging to assess for complications 3
• Routine imaging not needed for simple cystitis in men <40 without risk factors

Empiric Antibiotic Selection

For Complicated UTI with Systemic Symptoms (Hospitalized/Severe)

First-line empiric IV therapy 1:

• Amoxicillin + aminoglycoside, OR
• 2nd generation cephalosporin + aminoglycoside, OR
• 3rd generation cephalosporin (ceftriaxone 1-2g daily or cefotaxime 2g TID)

Alternative IV options (based on local resistance) 1:

• Ciprofloxacin 400mg IV BID or levofloxacin 750mg IV daily
• Piperacillin/tazobactam 2.5-4.5g TID
• Reserve carbapenems for multidrug-resistant organisms

For Outpatient/Oral Treatment

Fluoroquinolones remain the international standard 4, 5:

• Ciprofloxacin 500-750mg BID for 7-14 days
• Levofloxacin 750mg daily for 7-14 days

Critical caveat: Only use fluoroquinolones if local resistance <10% 1. Do NOT use if patient has used fluoroquinolones in last 6 months or is from urology department 1.

Fluoroquinolone-sparing alternatives (when resistance is concern) 4, 6:

• TMP-SMX 160/800mg BID for 7-14 days (comparable effectiveness to fluoroquinolones) 6
• Nitrofurantoin or pivmecillinam (3-5 days in Scandinavian guidelines, though associated with higher return visits) 4, 6
• β-lactams (modestly higher return visit rates but acceptable) 6

Treatment Duration

The critical decision point 1:

• 14 days: Default for men when prostatitis cannot be excluded (most cases)
• 7 days: Only if patient is hemodynamically stable, afebrile >48 hours, and prostatitis definitively ruled out
• Treatment duration should align with resolution of underlying abnormality

Common Pitfalls to Avoid

1. Don't treat based on urinalysis alone - Pyuria has extremely low positive predictive value and often represents non-infectious inflammation 7

2. Don't skip urine culture in men - Unlike uncomplicated cystitis in women, culture is essential in all men to guide therapy 1, 2

3. Don't use 3-day courses - Short courses appropriate for women are inadequate in men due to complicated nature 4

4. Don't empirically use fluoroquinolones in urology patients - Resistance rates are significantly higher 1

5. Don't forget to tailor therapy - Switch from empiric to culture-directed therapy once susceptibilities return

Special Considerations

Recurrent UTIs in Men

• Warrants urological evaluation for structural abnormalities
• Consider imaging (ultrasound, cystoscopy) especially if >40 years or risk factors present
• Evaluate for prostate pathology

Catheter-Associated UTI

• Different entity with 3-8% daily bacteriuria risk 1
• Mortality ~10% when progresses to bacteremia 1
• Remove/replace catheter when feasible before treating

The evidence base for male UTIs remains surprisingly limited - only 3 small RCTs exist comparing treatments 5, highlighting why guideline-based approaches emphasizing culture-directed therapy and adequate duration are paramount.